Identification and reconstruction of the binding site within alpha(M)beta(2) for a specific and high affinity ligand, NIF

被引:61
|
作者
Zhang, L
Plow, EF
机构
[1] Joseph J. Jacobs Ctr. Thromb. V., Department of Molecular Cardiology, Cleveland Clinic Foundation, Cleveland
关键词
D O I
10.1074/jbc.272.28.17558
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Engagement of the alpha(M) beta(2) (CD11b/CD18, Mac-1) integrin on neutrophils supports adhesion and induces various cellular responses. These responses can be blocked by a specific ligand of alpha M beta(2), neutrophil inhibitory factor (MF). The molecular basis of alpha(M) beta(2)-NIF interactions was studied. The single chain alpha(M) subunit, expressed on the surface of human 293 cells, bound NIF with an affinity equivalent to that of alpha(M) beta(2) heterodimer. This observation, coupled with previous data showing that the alpha(M)I domain alone supported high affinity NIF binding, indicated that the binding site for NIF is restricted to the I domain. Guided by the crystal structure of the alpha(M)I domain, 16 segments corresponding to the entire enter hydrated surface of alpha(M)I domain were switched to their counterparts sequences in alpha(L), which does not bind NIF. Surface expression and heterodimer formation were achieved for all mutants, and correct folding was confirmed. Of the 16 switches, only 5 affected NIF binding substantially, reducing affinity by 8-300-fold. These data confined the NIF-binding site to a narrow region composed of Pro(147)-Arg(152), Pro(201)-Lys(217), and Asp(248) Arg(261) of alpha(M). Verifying this localization, when these segments were introduced inter the alpha(X)I-domain, the resulting chimeric receptor was converted into a high affinity NIF-binding protein.
引用
收藏
页码:17558 / 17564
页数:7
相关论文
共 50 条
  • [1] Identification of amino acid residues within aMb2 required for recognition of a specific and high affinity ligand, NIF.
    Ustinov, VA
    Plow, EF
    BLOOD, 2000, 96 (11) : 611A - +
  • [2] Affinity modulation in platelet alpha 2 beta 1 following ligand binding
    GofferDadosh, N
    Klepfish, A
    Schmilowitz, H
    Shaklai, M
    Lahav, J
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2750 - P2750
  • [3] Affinity modulation in platelet alpha 2 beta 1 following ligand binding
    GoferDadosh, N
    Klepfish, A
    Schmilowitz, H
    Shaklai, M
    Lahav, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 232 (03) : 724 - 727
  • [4] IDENTIFICATION BY AFFINITY-CHROMATOGRAPHY OF HIGH-AFFINITY BINDING-SITES FOR ACTIVATED ALPHA-2M ON FIBROBLASTS
    HANOVER, JA
    WILLINGHAM, MC
    PASTAN, I
    FEDERATION PROCEEDINGS, 1983, 42 (07) : 2131 - 2131
  • [5] IDENTIFICATION OF A HIGH-AFFINITY BINDING-SITE ON TRANSDUCIN-ALPHA FOR PDE-GAMMA
    TAKEMOTO, DJ
    CUNNICK, J
    UDOVICHENKO, I
    TWAMLEY, C
    GONZALEZ, K
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 1360 - 1360
  • [6] Identification of a High-Affinity Neurosteroid Binding Site in Human Alpha1Beta3 GabaAR using a Photoreactive Thdoc Analog
    Chiara, David C.
    Wu, Bo
    Zhou, Xiaojuan
    Jayakar, Selwyn S.
    Titterton, Katherine
    Forman, Stuart A.
    Miller, Keith W.
    Bruzik, Karol S.
    Cohen, Jonathan B.
    BIOPHYSICAL JOURNAL, 2019, 116 (03) : 392A - 392A
  • [7] RECOMBINANT ALPHA(2)M RECEPTOR-BINDING DOMAIN BINDS TO THE ALPHA(2)M RECEPTOR WITH HIGH-AFFINITY
    HOLTET, TL
    NIELSEN, KL
    ETZERODT, M
    MOESTRUP, SK
    GLIEMANN, J
    SOTTRUPJENSEN, L
    THOGERSEN, HC
    BIOLOGY OF ALPHA2-MACROGLOBULIN, ITS RECEPTOR, AND RELATED PROTEINS, 1994, 737 : 480 - 482
  • [8] CA2+ AFFINITY IN ONCOMODULIN - SITE-SPECIFIC MUTATIONS WITHIN THE CD BINDING DOMAIN
    HENZL, MT
    TREVINO, CL
    BOSCHI, JM
    FASEB JOURNAL, 1992, 6 (01): : A211 - A211
  • [9] Affinity modulation of integrin alpha(M)beta(2) through a distinct site in I domain.
    Zhang, L
    Plow, EF
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 1433 - 1433
  • [10] RS 16566: A novel, high affinity ligand for the (R) zacopride binding site
    Eglen, RM
    Carter, DS
    Berger, J
    Clark, RD
    Bonhaus, DW
    Leung, E
    Flippin, LA
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 : P120 - P120